Full-Time

Associate Account Manager

Confirmed live in the last 24 hours

Schrödinger

Schrödinger

501-1,000 employees

Computational platform for biopharmaceutical research

Government & Public Sector
Enterprise Software
Biotechnology

Entry, Junior

Cambridge, MA, USA

Category
Customer Success Management
Sales & Account Management
Required Skills
Salesforce
Requirements
  • Bachelor’s degree in Chemistry, Biology, or a related science
  • One to two years of relevant work experience, software sales experience preferred
Responsibilities
  • Manage all team engagements with assigned accounts to ensure objectives are met
  • Develop and maintain exceptional account relationships through effective communication, education, reporting and problem-solving
  • Provide feedback from clients to the internal Product Managers and Support teams
  • Support Account Management team with prospecting, lead qualification and quote generation
  • Use Salesforce CRM to track account activities and progress
  • Work with marketing to implement and coordinate prospecting campaigns

Schrödinger provides a computational platform that aids in the research efforts of biopharmaceutical companies, academic institutions, and government laboratories around the world. Their platform offers advanced computational tools that help in drug discovery and research across various therapeutic areas. Schrödinger's products work by utilizing sophisticated algorithms and simulations to predict molecular behavior, which assists researchers in understanding how different compounds can interact with biological targets. What sets Schrödinger apart from its competitors is its extensive global reach, serving clients in over 70 countries, and its dual focus on both software licensing and collaborative drug discovery programs. The company's goal is to enhance scientific research and development by providing powerful tools and services that accelerate the drug discovery process.

Company Stage

IPO

Total Funding

$362.7M

Headquarters

New York City, New York

Founded

1990

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • $19.5M Gates Foundation grant boosts drug discovery for neglected diseases.
  • $10M grant enhances predictive toxicology tools, reducing drug development failures.
  • Collaboration with Avicenna Biosciences accelerates drug discovery through machine learning.

What critics are saying

  • Recursion and Exscientia merger increases competition in AI-driven drug discovery.
  • Avicenna's new platform poses a competitive threat to Schrödinger's offerings.
  • Rising drug discovery costs may strain Schrödinger's resources and timelines.

What makes Schrödinger unique

  • Schrödinger's platform supports diverse clients, including biopharmaceutical companies and academic institutions.
  • The company excels in rapid drug discovery, exemplified by the SGR-1505 development.
  • Schrödinger's commitment to ESG initiatives enhances its appeal to socially responsible investors.

Help us improve and share your feedback! Did you find this helpful?